Keywords: Servier, Prognpmix, Type 2 diabees, Research collaboration

Servier partners with Canada’s Prognomix on type 2 diabetes research

Article | 11 November 2011

Print This

Independent French drugmaker Laboratoires Servier has entered into an R&D agreement with privately-held Canadian company Prognomix, aimed at ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in